Biodesix Inc (BDSX) Stock: A Year of Stock Market Ups and Downs

THMO

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Biodesix Inc’s current trading price is -79.26% away from its 52-week high, while its distance from the 52-week low is 146.22%. The stock’s price range for this period has been between $0.17 and $2.04 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.02 million for the day, a number notably lower than the average daily volume of 9.03 million over the last three months.

The present stock price for Biodesix Inc (BDSX) is $0.42. In the last trading session, the stock made a considerable jump, reaching $2.0 after an opening price of $0.42. The stock briefly fell to $1.5 before ending the session at $0.38.

The market performance of Biodesix Inc’s stock has been turbulent in recent times.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Biodesix Inc (BDSX) has experienced a quarterly decline of -10.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 62.00M and boasts a workforce of 273 employees.

Biodesix Inc: What Analysts Are Saying

As of right now, 4 analysts are rating Biodesix Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4348, with a change in price of -0.3580. Similarly, Biodesix Inc recorded 5,827,856 in trading volume during the last 100 days, posting a change of -45.84%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BDSX stands at 5.63. Similarly, the long-term debt-to-equity ratio is also 5.53.

BDSX Stock Stochastic Average

As of today, Biodesix Inc’s raw stochastic average for the last 50 days stands at 84.43%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 80.47%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 64.23% and 56.41%, respectively.

BDSX Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -74.05% this year. Over the last six months, there has been a stronger performance of -58.12%. The price of BDSX fallen by 53.37% during the last 30 days period. For the last 5-days stocks have improved 8.99%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.